These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2172452)

  • 1. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.
    Martin S; Zhu XX; Silverstein SJ; Courtney RJ; Yao F; Jenkins FJ; Rouse BT
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2391-9. PubMed ID: 2172452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.
    Banks TA; Allen EM; Dasgupta S; Sandri-Goldin R; Rouse BT
    J Virol; 1991 Jun; 65(6):3185-91. PubMed ID: 1709698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
    Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
    Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.
    Martin S; Mercadal CM; Weir JP; Rouse BT
    Viral Immunol; 1993; 6(1):21-33. PubMed ID: 8386515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with the immediate-early protein ICP47 of herpes simplex virus-type 1 (HSV-1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge.
    Banks TA; Jenkins FJ; Kanangat S; Nair S; Dasgupta S; Foster CM; Rouse BT
    Virology; 1994 Apr; 200(1):236-45. PubMed ID: 8128625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.
    Witmer LA; Rosenthal KL; Graham FL; Friedman HM; Yee A; Johnson DC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():387-96. PubMed ID: 2155292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL; Smiley JR; South S; Johnson DC
    J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation by herpes simplex virus proteins ICP4 and ICP0 in vaccinia virus infected cells.
    Zhu XX; Papavassiliou AG; Stunnenburg HG; Silverstein S
    Virology; 1991 Sep; 184(1):67-78. PubMed ID: 1651605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
    Martin S; Cantin E; Rouse BT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant vaccinia virus expressing herpes simplex virus type 1 glycoprotein B induces cytotoxic T lymphocytes in mice.
    McLaughlin-Taylor E; Willey DE; Cantin EM; Eberle R; Moss B; Openshaw H
    J Gen Virol; 1988 Jul; 69 ( Pt 7)():1731-4. PubMed ID: 2839606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
    Martin S; Rouse BT
    J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
    J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.
    Martin S; Cantin E; Rouse BT
    Ann N Y Acad Sci; 1988; 532():257-72. PubMed ID: 2845846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
    Zarling JM; Moran PA; Lasky LA; Moss B
    J Virol; 1986 Aug; 59(2):506-9. PubMed ID: 3016312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
    Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
    J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of monoclonal antibodies directed against herpes simplex virus-specified glycoproteins on the generation of virus-specific and H-2-restricted cytotoxic T-lymphocytes.
    Sethi KK
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2033-7. PubMed ID: 6310041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.